Ionis Pharmaceuticals' Investigator‑Initiated Research Program funds independent studies advancing science in cardiovascular, hereditary angioedema, and neurological diseases.
Investigator-initiated Research (IIR) and Collaborative Research Grants support external investigators’ studies relevant to Neurocrine’s clinical programs to advance scientific knowledge and improve patient care.
Investigator Initiated Studies (IIS) supports external, non-commercial sponsors conducting independent clinical, observational, real-world evidence, and health outcomes research to explore scientific questions.
Investigator Initiated Studies (IIS) supports investigators and research sponsors conducting clinical studies to deepen understanding of Genentech medicines, improve patient care, and inspire disease research.
Investigator-Initiated Studies supports independent researchers through Sarepta Therapeutics funding or study materials to answer medical and scientific questions in rare neuromuscular diseases.